| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LTBP2 mRNA | affects expression | 16483693
|
| C015001 |
arsenite |
arsenite results in decreased expression of LTBP2 mRNA | decreases expression | 18929588
|
| C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of LTBP2 mRNA] | affects reaction|decreases expression | 18929588
|
| D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LTBP2 mRNA | affects cotreatment|increases expression | 18164116
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of LTBP2 mRNA | decreases expression | 20064835
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of LTBP2 mRNA | increases expression | 15336504
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LTBP2 mRNA | affects cotreatment|increases expression | 18164116
|
| D002117 |
Calcitriol |
Calcitriol results in increased expression of LTBP2 mRNA | increases expression | 16002434
|
| D004317 |
Doxorubicin |
LTBP2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of LTBP2 mRNA | increases expression | 12655037 15834898 16174780
|
| D005576 |
Forskolin |
Forskolin results in decreased expression of LTBP2 mRNA | decreases expression | 15313392
|
| D016685 |
Mitomycin |
LTBP2 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
| D017239 |
Paclitaxel |
LTBP2 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of LTBP2 mRNA | decreases expression | 16014739
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of LTBP2 mRNA | affects expression | 14699072
|
| D019772 |
Topotecan |
LTBP2 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
| D014747 |
Vinblastine |
LTBP2 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.58 | 14745880 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.07 | 20464547 20127859 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.07 | 17418594 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.07 | 14692618 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.22 | 6695378 |
| MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.22 | 19389873 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.22 | 10737359 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.92 | 19061943 19052882 17620307 16434500 18056438 17162532 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.73 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.93 | 16712894 17306315 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.55 | 21441931 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.73 | 14601052 |
| MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.57 | 15867366 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.81 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.97 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.97 | 11237771 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.97 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.97 | 16826403 16322301 16096432 16935488 18628466 16115903 16264153 15692762 15993339 17426702 18695136 17983394 15136595 11325840 15939500 15567936 19526202 15994142 15668708 16595493 18382427 18234424 15634643 17369602 |
| MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.97 | 16273361 18323546 18223236 15136595 18234424 11325840 16115903 16244791 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.97 | 19288272 19011961 19289846 15668708 19066611 21138602 18821012 18351453 18425577 18855134 20859285 18629630 16273361 19221464 17242785 11161223 17440819 19410462 19059307 17893378 21152245 19142967 20005174 19155303 18984771 19189210 18997820 20135344 19200415 19115204 19103187 16202921 20065188 15565566 19244106 19487384 16818667 18815881 16873071 19084267 17261762 19189212 20390343 17049068 20544844 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.84 | 16051944 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.52 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.90 | 17138121 20512989 17055752 19519916 20727157 20084675 17978847 19335982 18210153 18971187 17173139 16681979 19052882 3581430 16569478 17428255 3084413 20101231 19208518 19107877 19701751 18691550 10672840 19394651 16935385 18978308 20214788 19418558 19919837 19383236 16288022 17162532 19539802 20007298 17761372 20524982 16779866 20432363 11831363 16878318 18393292 16540662 21159647 18056438 18506893 18665156 19171122 10737359 16328049 19822196 16502159 18494052 16830150 16698587 16807293 18785209 20514400 18788625 20935162 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.90 | 16234567 17876044 18059187 16023760 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
8.90 | 16313753 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.90 | 17306315 16507464 15276417 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.90 | 16924424 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.96 | 16201981 1485588 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
6.96 | 1485588 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.83 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.83 | 11237771 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.83 | 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.83 | 18572023 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.62 | 17572228 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.53 | 17308081 16278810 16109756 17131338 17382496 16952015 17351982 16612575 15505089 15792986 17519947 17329180 15476868 17007740 18627295 17928571 16269455 17924179 16651473 16455267 16364871 16242529 16731534 15811867 17974986 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 17334414 16243910 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.78 | 21159647 7505956 17174075 2727394 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.78 | 20056578 19524636 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.69 | 19052882 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.88 | 17681005 17110522 16919318 17333356 16105132 15861022 11677210 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.59 | 15037631 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.66 | 18259882 18802399 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.66 | 18802399 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.66 | 18802399 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.38 | 19031437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.19 | 20387270 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.48 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.07 | 19107877 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.07 | 17416283 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.67 | 18602426 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
15.41 | 15138306 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
15.41 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
15.41 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.57 | 17359293 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.57 | 17893378 19155303 16202921 20544844 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.19 | 18037988 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.15 | 16302075 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.65 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.65 | 16481741 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
18.85 | 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
18.85 | 20387270 21071580 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.85 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.85 | 14986274 19224547 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.24 | 16709447 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.55 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.51 | 19069698 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.51 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
4.08 | 18296743 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.70 | 16452187 |
| OMIM:613086 |
GLAUCOMA 3, PRIMARY CONGENITAL, D |
marker/mechanism |
|
| |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.35 | 17150277 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.53 | 15692506 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.66 | 20471113 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.48 | 17875725 16879835 16495754 16244371 18006777 16144979 16244372 16707910 12587719 18674790 14766674 17888722 16330681 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.34 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.90 | 15692506 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
12.42 | 17606976 15147373 18501091 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
12.42 | 12676792 |
| MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
12.42 | 18501091 18180244 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.65 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.65 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.08 | 18785209 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.08 | 19457130 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.28 | 15699352 15369732 16775033 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.28 | 20008137 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.16 | 16707910 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.04 | 18625569 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.19 | 16085563 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.16 | 15342952 17567588 |
| MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.83 | 17353645 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.84 | 18296743 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.84 | 18407596 18522880 19638242 20032147 18665156 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.62 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.62 | 18564211 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.10 | 17034775 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
18.02 | 21137059 20195826 |
| MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
18.02 | 19389873 21295105 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.02 | 19073162 19090486 19499222 19996281 18754104 9163691 19426721 21167192 19690152 19427195 18644402 15885732 12771043 19833225 19254457 10737359 15175105 2422723 21278145 21071580 12112319 20118626 19294768 2862719 20137499 20583210 18648771 20501860 19812893 19256749 19638242 20492335 20101389 20405173 20452335 19551842 18977376 18978307 20434301 19642983 16942905 19850985 19255062 21047994 |
| MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
18.02 | 15113037 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
18.02 | 16712894 15276417 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
18.02 | 16684651 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.00 | 18164116 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.00 | 3124819 18775883 18282651 18544905 18253720 18079962 17942915 18093689 19004024 19519916 21159647 9362446 16842330 17174075 18308698 2563599 19009564 16267830 19126423 19539802 18164116 17854601 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.00 | 17085340 16842330 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.17 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
8.57 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.57 | 18816296 20064080 18569708 20135361 20464547 20869020 18520028 17053015 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.57 | 20970405 21163286 20512841 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.57 | 17418594 6189445 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.57 | 17306315 19931552 17077188 15276417 16712894 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.57 | 18625569 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.46 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.97 | 17654614 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
8.97 | 14749477 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.58 | 15621674 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.78 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.15 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.15 | 16827153 11731420 19196723 14580682 19196722 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.58 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.84 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.84 | 16342250 12025231 12040289 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.84 | 19082730 16487513 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.84 | 12393984 19393235 |
| MESH:D008545 |
Melanoma |
|
Vinblastine |
9.84 | 16432458 18332650 18505091 17761969 16809738 15577320 16248763 18176117 15577323 12374674 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.20 | 15990972 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.06 | 17638057 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.50 | 15792986 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.81 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.69 | 14749477 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.95 | 19429709 15857846 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
13.64 | 9029167 3581430 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
13.64 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
13.64 | 15867366 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
13.64 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.03 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.03 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.68 | 20056578 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.03 | 19196722 19189210 19200415 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.43 | 15738583 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.78 | 16899518 16636307 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.00 | 16889571 15640375 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.14 | 12854658 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.30 | 15555623 |
| MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.30 | 15176712 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.34 | 20387270 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.15 | 20387270 |
| MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.58 | 17378895 |
| MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.00 | 15867366 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.11 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
5.12 | 11161223 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.12 | 15276417 17306315 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.62 | 16540662 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
5.62 | 15113037 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.19 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.19 | 17638057 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.55 | 2563599 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.80 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.89 | 16289102 18247401 15754350 12479363 16644109 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.89 | 16888761 15897917 15749863 18437689 16868541 16729912 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.89 | 16356831 17172428 17136230 16729912 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 15861022 16919318 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.23 | 17922066 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.99 | 17710206 16767912 15675481 15625365 17203757 18313854 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.25 | 14601052 16326096 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.81 | 17846226 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.61 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.61 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.61 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.61 | 8532709 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.58 | 16767912 17203757 15625365 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.66 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.66 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.06 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.80 | 12854658 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.42 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.42 | 18456281 |
| MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.42 | 18396642 18506536 |
| MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.83 | 16930453 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.30 | 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.30 | 16010429 17909728 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.95 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.95 | 17653716 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.95 | 16712894 11723127 17306315 16452187 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.95 | 16712894 17572228 8653321 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.77 | 11813266 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.06 | 15577323 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.44 | 17056641 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 15869587 14671159 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.23 | 16364871 17678736 17638931 17334414 |